Moreover, HCC cells elevate PKM2 expression by preventing its degradation, as ubiquitin-specific protease 35 (USP35) stabilizes PKM2 through deubiquitination, promoting aerobic glycolysis and tumor progression (48). The gene discussed is PKM; the disease is hepatocellular carcinoma.